Perbedaan Organon Pharma Indonesia Tbk. dan Satria Mega Kencana Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Satria Mega Kencana Tbk. diperdagangkan di Rp600 (kapitalisasi pasar 610 M, volume 24 jam 587,5 rb). Perbedaan utamanya: Satria Mega Kencana Tbk. jauh lebih besar — sekitar 5,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SOTS | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 610 M |
Volume | — | 587,5 rb |
Lot | — | 5,88 rb |
Perputaran | — | 347,18 jt |
Harga Rata-rata | — | 590,95 |
Nilai Transaksi | — | 347,18 jt |
Harga Ekuilibrium Indikatif | — | 600 |
Volume Ekuilibrium Indikatif | — | 5 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Satria Mega Kencana Tbk (the Company) was established based on Notarial Deed No. 62 of Ilmiawan Dekrit Supatmo, S.H., dated June 16, 2004, notary in Jakarta.
Selengkapnya di halaman SOTS →